Is Vertex Stock Still a Good Buy?
Over the past ten years or so, Vertex Pharmaceuticals (NASDAQ:…
Sell
45
PKE Quote, Financials, Valuation and Earnings
Last price:
$13.09
Seasonality move
:
4.86%
Day range:
$13.03 - $13.36
52-week range:
$11.96 - $15.57
Dividend yield:
3.76%
P/E ratio:
36.92x
P/S ratio:
4.39x
P/B ratio:
2.47x
Volume:
31.8K
Avg. volume:
59.5K
1-year change:
-8.41%
Market cap:
$264.8M
Revenue:
$56M
EPS (TTM):
$0.36
| Period Ending | 2020-02-29 | 2021-03-01 | 2022-03-01 | 2023-03-01 | 2024-02-29 | |
|---|---|---|---|---|---|---|
| Revenue | $60M | -- | -- | -- | $56M | |
| Revenue Growth (YoY) | 17.41% | -- | -- | -- | 3.61% | |
| Cost of Revenues | $41.3M | -- | -- | -- | $39.5M | |
| Gross Profit | $18.7M | -- | -- | -- | $16.5M | |
| Gross Profit Margin | 31.11% | -- | -- | -- | 29.52% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $7.9M | -- | -- | -- | $8.2M | |
| Other Inc / (Exp) | -- | -- | -- | -- | -- | |
| Operating Expenses | $7.9M | -- | -- | -- | $8.2M | |
| Operating Income | $10.7M | -- | -- | -- | $8.4M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $14.1M | -- | -- | -- | $9.4M | |
| Earnings of Discontinued Ops. | -$653K | -- | -- | -- | -- | |
| Income Tax Expense | $3.9M | -- | -- | -- | $2M | |
| Net Income to Company | $9.6M | -- | -- | -- | $7.5M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $9.6M | -- | -- | -- | $7.5M | |
| Basic EPS (Cont. Ops) | $0.47 | -- | -- | -- | $0.37 | |
| Diluted EPS (Cont. Ops) | $0.47 | -- | -- | -- | $0.37 | |
| Weighted Average Basic Share | $20.5M | -- | -- | -- | $20.3M | |
| Weighted Average Diluted Share | $20.6M | -- | -- | -- | $20.4M | |
| EBITDA | $12.3M | -- | -- | -- | $9.8M | |
| EBIT | $10.7M | -- | -- | -- | $8.4M | |
| Revenue (Reported) | $60M | -- | -- | -- | $56M | |
| Operating Income (Reported) | $10.7M | -- | -- | -- | $8.4M | |
| Operating Income (Adjusted) | $10.7M | -- | -- | -- | $8.4M | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $10.4M | $13.9M | $13.9M | $11.6M | $14.4M | |
| Revenue Growth (YoY) | -34.55% | 33.67% | 0.02% | -16.07% | 23.79% | |
| Cost of Revenues | $7.8M | $10M | $9.4M | $8.5M | $10.6M | |
| Gross Profit | $2.6M | $3.8M | $4.4M | $3.2M | $3.8M | |
| Gross Profit Margin | 24.61% | 27.67% | 32.05% | 27.23% | 26.57% | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $1.5M | $1.6M | $1.5M | $1.8M | $2M | |
| Other Inc / (Exp) | -- | -$13K | -- | -- | -- | |
| Operating Expenses | $1.5M | $1.6M | $1.5M | $1.8M | $2M | |
| Operating Income | $1M | $2.2M | $2.9M | $1.4M | $1.8M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $1.4M | $2.3M | $3.2M | $1.6M | $2.1M | |
| Earnings of Discontinued Ops. | -$116K | -- | -- | -- | -- | |
| Income Tax Expense | $369K | $569K | $990K | $423K | $559K | |
| Net Income to Company | $921K | $1.7M | $2.2M | $1.2M | $1.6M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $921K | $1.7M | $2.2M | $1.2M | $1.6M | |
| Basic EPS (Cont. Ops) | $0.05 | $0.09 | $0.11 | $0.06 | $0.08 | |
| Diluted EPS (Cont. Ops) | $0.05 | $0.08 | $0.11 | $0.06 | $0.08 | |
| Weighted Average Basic Share | $20.4M | $20.5M | $20.5M | $20.3M | $20M | |
| Weighted Average Diluted Share | $20.4M | $20.5M | $20.5M | $20.4M | $20.1M | |
| EBITDA | $1.3M | $2.6M | $3.2M | $1.7M | $2.3M | |
| EBIT | $1M | $2.2M | $2.9M | $1.4M | $1.8M | |
| Revenue (Reported) | $10.4M | $13.9M | $13.9M | $11.6M | $14.4M | |
| Operating Income (Reported) | $1M | $2.2M | $2.9M | $1.4M | $1.8M | |
| Operating Income (Adjusted) | $1M | $2.2M | $2.9M | $1.4M | $1.8M | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $47.3M | $55.5M | $53M | $53.2M | $61.4M | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $33.4M | $37.5M | $36.2M | $37.3M | $44.3M | |
| Gross Profit | $13.9M | $18M | $16.8M | $15.9M | $17.1M | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $6.9M | $6.1M | $6.4M | $7.9M | $8M | |
| Other Inc / (Exp) | -- | -$197K | -$62K | -- | -$1.1M | |
| Operating Expenses | $6.9M | $6.1M | $6.4M | $7.9M | $8M | |
| Operating Income | $7M | $11.9M | $10.4M | $8M | $9.1M | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $9.3M | $10.6M | $11.1M | $9.2M | $9.2M | |
| Earnings of Discontinued Ops. | -$577K | -- | -- | -- | -- | |
| Income Tax Expense | $2.5M | $3.1M | $3.1M | -$331K | $1.9M | |
| Net Income to Company | $5.8M | $7.5M | $8M | $9.5M | $7.3M | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.2M | $7.5M | $8M | $9.5M | $7.3M | |
| Basic EPS (Cont. Ops) | $0.32 | $0.37 | $0.39 | $0.47 | $0.36 | |
| Diluted EPS (Cont. Ops) | $0.32 | $0.36 | $0.39 | $0.47 | $0.36 | |
| Weighted Average Basic Share | ||||||
| Weighted Average Diluted Share | ||||||
| EBITDA | $8.3M | $13M | $11.6M | $9.3M | $10.9M | |
| EBIT | $7M | $11.9M | $10.4M | $8M | $9.1M | |
| Revenue (Reported) | $47.3M | $55.5M | $53M | $53.2M | $61.4M | |
| Operating Income (Reported) | $7M | $11.9M | $10.4M | $8M | $9.1M | |
| Operating Income (Adjusted) | $7M | $11.9M | $10.4M | $8M | $9.1M | |
| Period Ending | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | 2025-11-30 | |
|---|---|---|---|---|---|---|
| Revenue | $41.1M | $40.5M | $39.7M | $61.4M | -- | |
| Revenue Growth (YoY) | -- | -- | -- | -- | -- | |
| Cost of Revenues | $27.4M | $27.9M | $27.6M | $44.3M | -- | |
| Gross Profit | $13.7M | $12.6M | $12.1M | $17.1M | -- | |
| Gross Profit Margin | -- | -- | -- | -- | -- | |
| R&D Expenses | -- | -- | -- | -- | -- | |
| Selling, General & Admin | $4.7M | $4.9M | $6.3M | $8M | -- | |
| Other Inc / (Exp) | -$197K | -- | -- | -$1.1M | -- | |
| Operating Expenses | $4.7M | $4.9M | $6.3M | $8M | -- | |
| Operating Income | $9M | $7.7M | $5.8M | $9.1M | -- | |
| Net Interest Expenses | -- | -- | -- | -- | -- | |
| EBT. Incl. Unusual Items | $9.1M | $8.4M | $6.5M | $9.2M | -- | |
| Earnings of Discontinued Ops. | -- | -- | -- | -- | -- | |
| Income Tax Expense | $2.6M | $2.4M | $1.7M | $1.9M | -- | |
| Net Income to Company | $6.5M | $6M | $4.8M | $7.3M | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | -- | |
| Net Income to Common Excl Extra Items | $6.5M | $6M | $4.8M | $7.3M | -- | |
| Basic EPS (Cont. Ops) | $0.32 | $0.29 | $0.24 | $0.36 | -- | |
| Diluted EPS (Cont. Ops) | $0.31 | $0.29 | $0.24 | $0.36 | -- | |
| Weighted Average Basic Share | $61.2M | $61.4M | $61M | $80.7M | -- | |
| Weighted Average Diluted Share | $61.7M | $61.5M | $61.2M | $81.1M | -- | |
| EBITDA | $9.8M | $8.6M | $6.8M | $10.9M | -- | |
| EBIT | $9M | $7.7M | $5.8M | $9.1M | -- | |
| Revenue (Reported) | $41.1M | $40.5M | $39.7M | $61.4M | -- | |
| Operating Income (Reported) | $9M | $7.7M | $5.8M | $9.1M | -- | |
| Operating Income (Adjusted) | $9M | $7.7M | $5.8M | $9.1M | -- | |
| Period Ending | 2020-02-29 | 2021-03-01 | 2022-03-01 | 2023-03-01 | 2024-02-29 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $5.4M | -- | -- | -- | $6.6M | |
| Short Term Investments | $116.9M | -- | -- | -- | $70.6M | |
| Accounts Receivable, Net | $10.9M | -- | -- | -- | $12.4M | |
| Inventory | $6.4M | -- | -- | -- | $6.4M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $5.5M | -- | -- | -- | $2.8M | |
| Total Current Assets | $145.2M | -- | -- | -- | $98.8M | |
| Property Plant And Equipment | $16.5M | -- | -- | -- | $23.6M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | $9.8M | -- | -- | -- | $9.8M | |
| Other Intangibles | $28K | -- | -- | -- | -- | |
| Other Long-Term Assets | $268K | -- | -- | -- | $94K | |
| Total Assets | $171.8M | -- | -- | -- | $132.3M | |
| Accounts Payable | $4.7M | -- | -- | -- | $3.5M | |
| Accrued Expenses | $1.6M | -- | -- | -- | $1.3M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $152K | -- | -- | -- | $53K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $8.7M | -- | -- | -- | $9.7M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $30.1M | -- | -- | -- | $19.4M | |
| Common Stock | $2.1M | -- | -- | -- | $2.1M | |
| Other Common Equity Adj | $668K | -- | -- | -- | -$2.3M | |
| Common Equity | $141.7M | -- | -- | -- | $112.9M | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $141.7M | -- | -- | -- | $112.9M | |
| Total Liabilities and Equity | $171.8M | -- | -- | -- | $132.3M | |
| Cash and Short Terms | $122.4M | -- | -- | -- | $77.2M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Cash and Equivalents | $3.8M | $14M | $4.6M | $4.2M | $12.8M | |
| Short Term Investments | $113.2M | $95.7M | $98.7M | $69.8M | $57.3M | |
| Accounts Receivable, Net | $8.4M | $9.7M | $8.9M | $9.9M | $9.7M | |
| Inventory | $4.7M | $5.2M | $6.8M | $7.4M | $10.6M | |
| Prepaid Expenses | -- | -- | -- | -- | -- | |
| Other Current Assets | $3.8M | $3.2M | $4.3M | $2.5M | $2.2M | |
| Total Current Assets | $133.9M | $127.7M | $123.3M | $93.8M | $92.6M | |
| Property Plant And Equipment | $20.8M | $24.1M | $24.4M | $23.9M | $21.8M | |
| Long-Term Investments | -- | -- | -- | -- | -- | |
| Goodwill | -- | -- | -- | -- | -- | |
| Other Intangibles | -- | -- | -- | -- | -- | |
| Other Long-Term Assets | $160K | $141K | $112K | $98K | $83K | |
| Total Assets | $164.6M | $161.7M | $157.6M | $127.5M | $124.2M | |
| Accounts Payable | $3.3M | $2.2M | $2.4M | $1.1M | $5.5M | |
| Accrued Expenses | $1.5M | $1.7M | $1.3M | $1.6M | $1.4M | |
| Current Portion Of Long-Term Debt | -- | -- | -- | -- | -- | |
| Current Portion Of Capital Lease Obligations | $113K | $53K | $53K | $53K | $39K | |
| Other Current Liabilities | -- | -- | -- | -- | -- | |
| Total Current Liabilities | $7.2M | $6.5M | $6.3M | $6.4M | $12.3M | |
| Long-Term Debt | -- | -- | -- | -- | -- | |
| Capital Leases | -- | -- | -- | -- | -- | |
| Total Liabilities | $27.1M | $25M | $24M | $15.5M | $16.9M | |
| Common Stock | $2.1M | $2.1M | $2.1M | $2.1M | $2.1M | |
| Other Common Equity Adj | $272K | -$830K | -$4.3M | -$2.9M | -$965K | |
| Common Equity | -- | -- | -- | -- | -- | |
| Total Preferred Equity | -- | -- | -- | -- | -- | |
| Minority Interest, Total | -- | -- | -- | -- | -- | |
| Total Equity | $137.5M | $136.8M | $133.6M | $112M | $107.4M | |
| Total Liabilities and Equity | $164.6M | $161.7M | $157.6M | $127.5M | $124.2M | |
| Cash and Short Terms | $117M | $109.6M | $103.3M | $74M | $70M | |
| Total Debt | -- | -- | -- | -- | -- | |
| Period Ending | 2020-02-29 | 2021-03-01 | 2022-03-01 | 2023-03-01 | 2024-02-29 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $9.6M | -- | -- | -- | $7.5M | |
| Depreciation & Amoritzation | $1.5M | -- | -- | -- | $1.4M | |
| Stock-Based Compensation | $726K | -- | -- | -- | $529K | |
| Change in Accounts Receivable | -$1.6M | -- | -- | -- | -$2.4M | |
| Change in Inventories | -$1.1M | -- | -- | -- | $364K | |
| Cash From Operations | $5.2M | -- | -- | -- | $4.4M | |
| Capital Expenditures | $6.8M | -- | -- | -- | $645K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -$42.5M | -- | -- | -- | $31.4M | |
| Dividends Paid (Ex Special Dividend) | -$28.7M | -- | -- | -- | -$30.6M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -$2.9M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$28.3M | -- | -- | -- | -$33.5M | |
| Beginning Cash (CF) | $71M | -- | -- | -- | $4.2M | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$65.6M | -- | -- | -- | $2.3M | |
| Ending Cash (CF) | $5.4M | -- | -- | -- | $6.6M | |
| Levered Free Cash Flow | -$1.6M | -- | -- | -- | $3.8M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | -- | -- | |
| Depreciation & Amoritzation | -- | -- | -- | -- | -- | |
| Stock-Based Compensation | -- | -- | -- | -- | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | -- | -- | |
| Capital Expenditures | -- | -- | -- | -- | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -- | -- | |
| Special Dividend Paid | -- | -- | $1M | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | -- | -- | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | -- | -- | -- | -- | -- | |
| Period Ending | 2020-11-30 | 2021-11-30 | 2022-11-30 | 2023-11-30 | 2024-11-30 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | $5.8M | $7.5M | $8M | $9.5M | $7.3M | |
| Depreciation & Amoritzation | $1.3M | $1.1M | $1.2M | $1.3M | $1.8M | |
| Stock-Based Compensation | $464K | $260K | $348K | $520K | $399K | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | $11.2M | $8M | $7.1M | $3.5M | $9M | |
| Capital Expenditures | $7.7M | $5.8M | $1.5M | $779K | $422K | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | $16.2M | $9.6M | -$8.4M | $29.1M | $13.8M | |
| Dividends Paid (Ex Special Dividend) | -$28.7M | -$8.2M | -$8.2M | -$30.1M | -$10.1M | |
| Special Dividend Paid | ||||||
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -$1.6M | -- | -- | -$2.9M | -$4.3M | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -$30.3M | -$7.4M | -$8M | -$33M | -$14.3M | |
| Beginning Cash (CF) | -- | -- | -- | -- | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -$2.9M | $10.2M | -$9.4M | -$437K | $8.6M | |
| Ending Cash (CF) | -- | -- | -- | -- | -- | |
| Levered Free Cash Flow | $3.5M | $2.2M | $5.5M | $2.7M | $8.6M | |
| Period Ending | 2021-03-31 | 2022-03-31 | 2023-03-31 | 2024-03-31 | 2025-03-31 | |
|---|---|---|---|---|---|---|
| Net Income to Stockholders | -- | -- | -- | $2.7M | -- | |
| Depreciation & Amoritzation | -- | -- | -- | $418K | -- | |
| Stock-Based Compensation | -- | -- | -- | $104K | -- | |
| Change in Accounts Receivable | -- | -- | -- | -- | -- | |
| Change in Inventories | -- | -- | -- | -- | -- | |
| Cash From Operations | -- | -- | -- | $5.3M | -- | |
| Capital Expenditures | -- | -- | -- | $164K | -- | |
| Cash Acquisitions | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -$395K | -- | |
| Dividends Paid (Ex Special Dividend) | -- | -- | -- | -$2.5M | -- | |
| Special Dividend Paid | -- | -- | $1M | -- | -- | |
| Long-Term Debt Issued | -- | -- | -- | -- | -- | |
| Long-Term Debt Repaid | -- | -- | -- | -- | -- | |
| Repurchase of Common Stock | -- | -- | -- | -- | -- | |
| Other Financing Activities | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -$2.5M | -- | |
| Beginning Cash (CF) | -- | -- | -- | $4.2M | -- | |
| Foreign Exchange Rate Adjustment | -- | -- | -- | -- | -- | |
| Additions / Reductions | -- | -- | -- | $2.4M | -- | |
| Ending Cash (CF) | -- | -- | -- | $6.6M | -- | |
| Levered Free Cash Flow | -- | -- | -- | $5.1M | -- | |
Get PKE Stock Alert
Signup to receive the latest stock alerts
Financial Ratios
PKE
Sector
P/E ratio
36.92x
16.93x
PEG ratio
--
0.27x
P/B ratio
2.47x
1.64x
Price / LTM sales
4.39x
0.88x
Growth Metrics
PKE
Sector
Revenue growth
23.79%
2.89%
Earnings growth
33.33%
5.54%
Revenue (5-year growth)
1.84%
4.44%
Earnings forecast
--
$0.29
Profitability
PKE
Sector
Profitability FY 2023
$16.5M
$409.9M
Return on invested capital
6.59%
5.7%
Return on assets
5.72%
3.52%
Return on equity
6.59%
8.59%
Earnings Date
Last Earnings Date
Jan
14
Next Earnings Date
May
30
Estimated Next Earnings Date
Apr
15
Balance Sheet
PKE
Sector
Total cash
$70M
$163.9M
Short term investments
$70.6M
$38.8M
Total assets
$132.3M
$1.8B
Long term debt
--
$282.4M
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
58
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
56
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
20
EVVTY alert for May 1
Evolution AB [EVVTY] is down 19.01% over the past day.
Sell
47
LANC alert for May 1
Lancaster Colony [LANC] is down 15.56% over the past day.
Sell
36
BHE alert for May 1
Benchmark Electronics [BHE] is down 15.02% over the past day.
THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS
Show me the best stock
